Table of Contents Table of Contents
Previous Page  724 / 1578 Next Page
Information
Show Menu
Previous Page 724 / 1578 Next Page
Page Background

Reporting dose

Lax et al. 1993:

Ø

Normalizing to the 65%-isodose leads to a 50% increase of dose in

the target center without substantial increase of dose outside the

PTV in comparison to dose loads for a homogenous dose

distribution

This is all very nice, but how do we know what exactly was

reported in literature? To quote ICRU 91:

Ø

“Despite the long clinical history of SRT for intracranial lesions, at the

time of writing of this report, around

14 000 clinical manuscripts

on

stereotactic radiotherapy have been reported in PubMed with Phase

III studies only in brain metastases.

Prescribing, reporting, and

recording are performed in different ways at different

institutions which emphasizes the need for the present Report

to standardize the process

.”

SBRT 2017 - D. Verellen